1. Home
  2. FEMY vs WAI Comparison

FEMY vs WAI Comparison

Compare FEMY & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • WAI
  • Stock Information
  • Founded
  • FEMY 2004
  • WAI 2018
  • Country
  • FEMY United States
  • WAI China
  • Employees
  • FEMY N/A
  • WAI N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • WAI
  • Sector
  • FEMY Health Care
  • WAI
  • Exchange
  • FEMY Nasdaq
  • WAI NYSE
  • Market Cap
  • FEMY 29.9M
  • WAI 5.5M
  • IPO Year
  • FEMY 2021
  • WAI 2023
  • Fundamental
  • Price
  • FEMY $0.84
  • WAI $0.45
  • Analyst Decision
  • FEMY Strong Buy
  • WAI
  • Analyst Count
  • FEMY 3
  • WAI 0
  • Target Price
  • FEMY $8.67
  • WAI N/A
  • AVG Volume (30 Days)
  • FEMY 158.0K
  • WAI 5.7M
  • Earning Date
  • FEMY 08-07-2025
  • WAI 08-24-2025
  • Dividend Yield
  • FEMY N/A
  • WAI N/A
  • EPS Growth
  • FEMY N/A
  • WAI N/A
  • EPS
  • FEMY N/A
  • WAI N/A
  • Revenue
  • FEMY $1,699,232.00
  • WAI $3,750,352.00
  • Revenue This Year
  • FEMY $283.83
  • WAI N/A
  • Revenue Next Year
  • FEMY $161.03
  • WAI N/A
  • P/E Ratio
  • FEMY N/A
  • WAI N/A
  • Revenue Growth
  • FEMY 61.97
  • WAI N/A
  • 52 Week Low
  • FEMY $0.69
  • WAI $0.33
  • 52 Week High
  • FEMY $1.80
  • WAI $20.00
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 37.62
  • WAI N/A
  • Support Level
  • FEMY $0.91
  • WAI N/A
  • Resistance Level
  • FEMY $0.93
  • WAI N/A
  • Average True Range (ATR)
  • FEMY 0.04
  • WAI 0.00
  • MACD
  • FEMY -0.01
  • WAI 0.00
  • Stochastic Oscillator
  • FEMY 5.12
  • WAI 0.00

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About WAI TOP KINGWIN LTD

Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).

Share on Social Networks: